We use cookies, including third-party cookies from Google to serve personalized ads through AdSense, to operate this site and understand how it is used. By continuing to browse, you accept this use. See our Privacy Policy and Terms of Use for details, including how to opt out of personalized advertising.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: HIPAA Enforcement: Who’s in Charge?
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Policy & Law > HIPAA Enforcement: Who’s in Charge?
Policy & Law

HIPAA Enforcement: Who’s in Charge?

David Harlow
David Harlow
Share
0 Min Read
SHARE
Headscratch flickr cc san_drino

The recent Headscratch flickr cc san_drino

The recent FTC decision in the LabMD case (pdf) (full docket here) has HIPAA-watchers scratching their heads, tugging their beards, and generally wondering about reconciling FTC-style litigation-based regulation with OCR-style rule-based regulation of health care data privacy and security.

Here’s my take: For a covered entity or business associate that has all its ducks in a row – HIPAA Privacy, Security and (for Covered Entities) Breach Notification policies and procedures, a completed risk analysis, training and testing of workforce documented – FTC regulation should not be problematic. I think that the FTC would be hard-pressed to find an entity that is in compliance with HHS HIPAA rules and relevant state law to be in violation of the FTC Act’s prohibition of “unfair … acts or practices.”

The FTC does not have specific rules in place in this area, and is not likely to promulgate rules (it has rules in place for PHR breach notification, under the HITECH Act, but that is outside of HIPAA jurisdiction). The FTC regulates unfair acts or practices by filing complaints and dealing with violations of its basic statute on a case-by-case basis. It is not unreasonable for the FTC to assert that it has overlapping jurisdiction with OCR jurisdiction under HIPAA. Fines under the FTC Act are limited to $16,000 per violation (as opposed to the maximum fine of $1.5 million under HIPAA).

More Read

Organic Pharmacies
What Is An Apothecary? A Quick History Of Organic Pharmacies
Big Data: How We Communicate Vaccine Matters
Path Dependency in Health Reform: The Case of Medicare
Engagement: Finding the Healthy Mix
Health Insurance Benefits: Can You Have It Your Way?

The FTC asserting jurisdiction should be of concern for entities subject to HIPAA that are not in compliance with HIPAA – like LabMD in this case.

Ultimately, however, the question arises: What would the FTC do in any particular case that OCR would not already do? If both are actively enforcing HIPAA, then I would conclude: not much.

The same question arose when state attorneys general were given permission under HITECH to enforce HIPAA violations.  State AGs and the OCR often came up with parallel enforcement plans, so the value of the added enforcement agency appears to be limited. Of course, this may change over time if OCR enforcement scales back, the office is defunded, etc. In such a scenario, the federales may conclude that double-teaming the bad guys wasn’t such a bad idea after all.

Bottom line: Comply with the rules, rather than worrying about who has the authority to nail you when you don’t.

Photo: flickr cc san_drino

TAGGED:HIPAApatient datapatient privacy
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5KFollowersLike
4.5KFollowersFollow
2.8KFollowersPin
136KSubscribersSubscribe

Latest News

Flat editorial illustration: Core relationship is dual-track recovery where family support improves outcomes only when families m
Supporting a Loved One Through Addiction Recovery
Addiction Recovery
October 13, 2026
Flat editorial illustration: The article's core relationship is that substantial clinical testing of thymosin alpha-1 did not est
Thymosin Alpha-1 Got the Big Trials Most Peptides Never Get
Global Healthcare
October 12, 2026
Flat editorial illustration: The article examines how researchers study tissue repair through growth factors and peptide-based re
How Researchers Study Tissue Repair: From Growth Factors to Peptide-Based Research
Health
October 12, 2026
Workers Comp Claim Denied – Now What?  -- AI-generated illustration
Workers Comp Claim Denied – Now What? 
Policy & Law
October 9, 2026

You Might also Like

Global Healthcare

Project Diabetes 11.11.11 Ideas

November 6, 2011
The impact of US healthcare spending
BusinessFinanceGlobal HealthcareHealth ReformPublic Health

The Impact of US Healthcare Spending [INFOGRAPHIC]

February 19, 2014

5 Options For Victims of Domestic Abuse

January 8, 2013
patient documentation
Hospital AdministrationMedical RecordsTechnology

How to Train Your Dragon: Patient Documentation in the 21st Century

June 5, 2014
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2026 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?